findmyKOL

Christopher Girkin, MD

Enriched profile

Interim Chair and Professor, Viterbi Family Department of Ophthalmology; Viterbi Family Chair of Optic Nerve Biology · University of California San Diego

ORCIDNPI
Region🇺🇸 San Diego, CA · West · United StatesSpecialtyOphthalmologyFocusGlaucoma+1
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2024Online presenceverified 2026Payments2021–2025NIH funding2025–2026

Christopher Girkin is Interim Chair and Professor, Viterbi Family Department of Ophthalmology; Viterbi Family Chair of Optic Nerve Biology at University of California San Diego. OpenAlex indexes 505 publications with 14,176 citations (h-index 63); ClinicalTrials.gov lists 3 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Ophthalmology profiles in the findmyKOL directory.

Data verified 14 Aug 2026

Overview

Updated 31 Aug 2026

Christopher Girkin, MD, is Interim Chair and Professor, Viterbi Family Department of Ophthalmology at University of California San Diego, Shiley Eye Institute / Viterbi Family Department of Ophthalmology. The public record shows 505 publications with 14,176 citations (h-index 63), centered on Glaucoma, Diabetic Retinopathy / DME. It also documents an investigator role on 3 registered clinical trials, industry payments reported by 7 companies, 1 NIH-funded awards (2025–2026).

  • Top research focus: Glaucoma
  • 3 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 7 companies

Generated from the cited public record · current as of 31 Aug 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Glaucoma3 trialsComa3 trialsDiabetic Complications1 trialDiabetic Retinopathy / DME1 trialCataract1 trialDiabetic Retinopathy1 trialRefractive Errors1 trial

Research focus

OpenAlex concept fingerprint
GlaucomaDiabetic Retinopathy / DME

Drugs & molecules

across trials, industry payments and publications
Durystageneric · BimatoprostClinical trialsIndustry payments2PublicationsCequageneric · CyclosporineClinical trialsIndustry payments1Publications

Works with

trial sponsors and companies reporting payments
Alcon Vision LLCClinical trialsIndustry payments7Abbvie Inc.Clinical trialsIndustry payments4Topcon Healthcare, Inc.Clinical trialsIndustry payments3

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
505publications

Distinct works indexed by OpenAlex, matched via ORCID.

14,176citations

Total citations across indexed works.

63h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
3clinical trials

Investigator role on registered studies.

View trials
7companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments
1NIH grants · 2025–2026

Federally funded research awards.

View funding

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 31 Aug 2026

Listed as an investigator on 3 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 31 Aug 2026

7 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Sensory organs

    95.5%
    Prostaglandin Analog44.2%
    Latanoprost91%Lumigan7%Tafluprost2%Travoprost1%
    Part D<11 patients
    Carbonic Anhydrase Inhibitor27%
    Dorzolamide-Timolol57%Dorzolamide Hcl31%Simbrinza6%Brinzolamide6%
    Part D<11 patients
  • Cardiovascular

    2.8%
    Beta blocker2.8%
    Timolol Maleate100%
    Part D20 patients
  • Musculoskeletal

    1.7%
    Cyclooxygenase Inhibitor1.7%
    Ketorolac Tromethamine100%
    Part D26 patients
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 31 Aug 2026

1 NIH research award on record, funded 20252026 per NIH RePORTER. The latest:

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Online presence

Updated 31 Aug 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • ResearchGate

    researchgate.net/profile/Christopher-Girkin

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net

Mentions by others

where others cite or feature them
  • LinkedIn

    linkedin.com/posts/uab-callahan-eye_cynthia-owsley-phd-andchris-girkin-md-activity-7237105126350426112-6hpE

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com
  • LinkedIn

    linkedin.com/posts/uab-callahan-eye_uab-ophthalmology-researchers-christopher-activity-7217518707579744258-5DYy

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com
  • LinkedIn

    linkedin.com/posts/uc-san-diego-shiley-eye-center_welcome-seifaculty-glaucomacare-activity-7259595534682775553-NeLn

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com
4 more mentions behind the reveal.Reveal →

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 31 Aug 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • MD

    University of Arkansas

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →shileyeye.ucsd.edu
  • verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →shileyeye.ucsd.edu
  • verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →shileyeye.ucsd.edu
  • Residency

    Ophthalmology and Visual Sciences, University of Alabama at Birmingham

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →shileyeye.ucsd.edu
  • Fellowship

    Neuro-ophthalmology, Wilmer Eye Institute, Johns Hopkins University

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →shileyeye.ucsd.edu
  • Fellowship

    Glaucoma, Shiley Eye Institute, UC San Diego (Heed Glaucoma Fellow, Hamilton Glaucoma Center)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →shileyeye.ucsd.edu

Editorial & leadership roles

journal and society appointments
  • Interim Chair

    Viterbi Family Department of Ophthalmology, UC San Diego

    2026
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →shileyeye.ucsd.edu
  • Immediate Past President

    American Glaucoma Society

    2023
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.ucsd.edu
  • Former Department Chair

    Ophthalmology and Visual Sciences, University of Alabama at Birmingham (2012-2022); Founder, UAB Glaucoma Division

    1999
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.ucsd.edu
1 more role behind the reveal.Reveal →

Awards & honors

honors on the public record
5 more awards behind the reveal.Reveal →

Secondary affiliations

appointments beyond the home institution

Media & interviews

press, podcasts and appearances
  • Community Lecture Series speaker

    "Dr. Christopher A. Girkin", Shiley Eye Institute public lecture

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →shileyeye.ucsd.edu

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.